Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec 6;18(12):2633.
doi: 10.3390/ijms18122633.

Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson's and Alzheimer's Diseases

Anna A Boyko  1 , Natalya I Troyanova  2 , Elena I Kovalenko  3 , Alexander M Sapozhnikov  4
Affiliations
Review

Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson's and Alzheimer's Diseases

Anna A Boyko et al. Int J Mol Sci. .

Abstract

Parkinson's disease (PD) and Alzheimer's disease (AD) are the most common age-related neurodegenerative disorders. Both diseases are characterized by chronic inflammation in the brain-neuroinflammation. The first signs of PD and AD are most often manifested in old age, in which the immune system is usually characterized by chronic inflammation, so-called "inflammaging" In recent years, there is growing evidence that pathogenesis of these diseases is connected with both regional and peripheral immune processes. Currently, the association of clinical signs of PD and AD with different characteristics of patient immune status is actively being researched. In this mini-review we compare the association of PD and AD alterations of a number of immune system parameters connected with the process of inflammation.

Keywords: Alzheimer’s disease; Parkinson’s disease; cytokines; inflammation; neuroinflammation; oxidative stress; peripheral immune system.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Selkoe D.J. Cell biology of protein misfolding: The examples of Alzheimer’s and Parkinson’s diseases. Nat. Cell Biol. 2004;6:1054–1061. doi: 10.1038/ncb1104-1054. - DOI - PubMed
    1. Tan J.M., Wong E.S., Lim K.L. Protein misfolding and aggregation in Parkinson’s disease. Antioxid. Redox Signal. 2009;11:2119–2234. doi: 10.1089/ars.2009.2490. - DOI - PubMed
    1. Ebrahimi-Fakhari D., Wahlster L., McLean P.J. Molecular chaperones in Parkinson’s disease—Present and future. J. Parkinsons Dis. 2011;1:299–320. - PMC - PubMed
    1. Bloom G.S. Amyloid-β and tau: The trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014;71:505–508. doi: 10.1001/jamaneurol.2013.5847. - DOI - PubMed
    1. Wakabayashi K., Tanji K., Odagiri S., Miki Y., Mori F., Takahashi H. The Lewy body in Parkinson’s disease and related neurodegenerative disorders. Mol. Neurobiol. 2013;47:495–508. doi: 10.1007/s12035-012-8280-y. - DOI - PubMed

LinkOut - more resources